{"disease":{"id":"chemoradiotherapy","name":"chemoradiotherapy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06219083","title":"Nutritional Status and Clinical Outcomes in Patients With Common Malignancies(NCOM)","phase":"","overall_status":"RECRUITING","enrollment_count":1538,"lead_sponsor_name":"Xiaoqin Luo","has_results":false},{"nct_id":"NCT05828875","title":"A Multicenter, Cross-sectional Study on the Quality of Life in Long-term Survival Esophageal Cancer Patients After Radical Radiochemotherapy/Radiotherapy","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT07417800","title":"Construction and Clinical Validation of a Predictive Model for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma Based on Whole-Slide Digital Pathological Images and Deep Learning","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT05953181","title":"Statistical Analysis Plan for the SANO-trial: Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Active Surveillance for Oesophageal Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":776,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT07290972","title":"Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India","phase":"","overall_status":"RECRUITING","enrollment_count":618,"lead_sponsor_name":"Tata Memorial Hospital","has_results":false},{"nct_id":"NCT03493880","title":"The Analysis of Immuno-Nutrition Index in Advanced Gastric Cancer Receiving Preoperative Treatments","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Peking University","has_results":false},{"nct_id":"NCT03286348","title":"Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06734702","title":"Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":497,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT03177382","title":"Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":458,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT06288373","title":"Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":440,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT06758830","title":"Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos","has_results":false},{"nct_id":"NCT04737551","title":"Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT07509632","title":"Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":320,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT04227886","title":"Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT07177794","title":"Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCC","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":242,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06984289","title":"US Radiomics in Advanced Cervical Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT06413342","title":"Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":191,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT04648020","title":"Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer.","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":190,"lead_sponsor_name":"Monopar Therapeutics","has_results":false},{"nct_id":"NCT06794099","title":"Study on the Applicability of CCR Criteria in Rectal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":177,"lead_sponsor_name":"Peking University Cancer Hospital & Institute","has_results":false},{"nct_id":"NCT04013347","title":"Outcomes of Resection at Different Times Between the End of Neoadjuvant Treatment and Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"Campus Bio-Medico University","has_results":false},{"nct_id":"NCT04199832","title":"To Compare the Effect of Different Nutritional Pathways on Improving Nutritional Status of Esophageal Cancer Patients Undergoing Chemoradiotherapy","phase":"","overall_status":"COMPLETED","enrollment_count":156,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT06256224","title":"Toripalimab Combined With Definitive CCRT for LACC Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT03381651","title":"Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma","phase":"NA","overall_status":"COMPLETED","enrollment_count":147,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT05735145","title":"Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":108,"lead_sponsor_name":"Fourth Affiliated Hospital of Guangxi Medical University","has_results":false},{"nct_id":"NCT07198165","title":"SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":104,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT06833801","title":"Application of Intelligent Care Systems in Radiation Therapy: Enhancing Patient Safety and Reducing Anxiety Through System Optimization and Real-Time Blood Data Monitoring","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Chung Shan Medical University","has_results":false},{"nct_id":"NCT05325554","title":"Multi-mode Rehabilitation of Abdominal Tumor Patients Undergoing Concurrent Chemoradiotherapy","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Zhongnan Hospital","has_results":false},{"nct_id":"NCT06617052","title":"Preoperative (Chemo)Radiotherapy for Locally Recurrent Rectal Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false},{"nct_id":"NCT07131670","title":"Symptoms Burden in Lung Cancer Patients Undergoing Definitive Chemoradiotherapy: Insights From Electronic Patient-Reported Outcomes","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Qian Chu","has_results":false},{"nct_id":"NCT06736678","title":"Oral Immunonutrition Therapy to Reduce Acute Toxicity After Neoadjuvant Chemoradiotherapy Pancreatic Cancer Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":98,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06190847","title":"Oral Microbiome is Associated With the Response to Chemoradiotherapy in Initial Inoperable Patients With Esophageal Squamous Cell Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":97,"lead_sponsor_name":"Anhui Provincial Hospital","has_results":false},{"nct_id":"NCT05311566","title":"PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":92,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT07086456","title":"Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT05341206","title":"Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study.","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT07248020","title":"A Phase II Single-Arm Study of High-Bioavailability Curcumin as Neoadjuvant Chemoradiotherapy in Mid-to-Low Rectal Cancer: Integrated Clinical and Translational Analysis of Tumor Tissue","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":72,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT05833594","title":"Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma","phase":"","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Anhui Provincial Hospital","has_results":false},{"nct_id":"NCT04764227","title":"Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":70,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT03623347","title":"Upfront Bevacizumab/témozolomide for Gliomastomas With Neurological Impairment","phase":"","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Centre Hospitalier Universitaire, Amiens","has_results":false},{"nct_id":"NCT07086469","title":"Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":69,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07063888","title":"A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":66,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT04815694","title":"THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":63,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT06421376","title":"Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT03963882","title":"NAC Followed by RH for the Treatment of LACC","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT05863260","title":"Tislelizumab Combing Chemoradiotherapy in Recurrent Cervical Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06342167","title":"Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":57,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT06429839","title":"Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":55,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT04207918","title":"A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT06410651","title":"Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":53,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT06197776","title":"Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT05969938","title":"Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"WeiWei Xiao","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}